A detailed history of Kingsview Wealth Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 5,122 shares of DXCM stock, worth $412,679. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,122
Previous 14,124 63.74%
Holding current value
$412,679
Previous $1.6 Million 78.58%
% of portfolio
0.01%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $576,128 - $1.04 Million
-9,002 Reduced 63.74%
5,122 $343,000
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $83,394 - $106,180
-756 Reduced 5.08%
14,124 $1.6 Million
Q1 2024

May 09, 2024

BUY
$114.22 - $140.1 $70,016 - $85,881
613 Added 4.3%
14,880 $2.06 Million
Q4 2023

Feb 08, 2024

BUY
$75.49 - $124.16 $1.08 Million - $1.77 Million
14,267 New
14,267 $1.77 Million
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $194,685 - $226,726
1,731 New
1,731 $222,000
Q2 2022

Aug 16, 2022

SELL
$67.99 - $132.89 $704,376 - $1.38 Million
-10,360 Reduced 79.13%
2,732 $204,000
Q1 2022

Feb 08, 2024

SELL
$94.08 - $130.2 $508,972 - $704,381
-5,410 Reduced 37.92%
8,857 $1.13 Million
Q4 2021

Feb 17, 2022

BUY
$129.87 - $162.82 $101,298 - $126,999
780 Added 6.34%
13,092 $7.03 Million
Q3 2021

Dec 03, 2021

BUY
$106.71 - $143.18 $84,727 - $113,684
794 Added 6.89%
12,312 $6.73 Million
Q2 2021

Aug 17, 2021

BUY
$80.99 - $107.93 $205,228 - $273,494
2,534 Added 28.21%
11,518 $4.92 Million
Q1 2021

May 24, 2021

BUY
$84.79 - $104.74 $332,292 - $410,476
3,919 Added 77.37%
8,984 $3.28 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $395,070 - $529,292
5,065 New
5,065 $1.87 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.